Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class ASSE: 688505

Announcement on the Voluntary Disclosure of Non-Approval of the Marketing Authorization Application for Obeticholic Acid Tablets for the Treatment of Primary Biliary Cholangitis

· Issued by Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on the Voluntary Disclosure of Non-Approval of the Marketing Authorization Application for Obeticholic Acid Tablets for the Treatment of Primary Biliary Cholangitis

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis